Medical Polymer Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global medicalpolymer market size is expected to touch USD 38.3 Billion by 2030, from USD 18.9 Billion in 2021, growing with a significant CAGR of 8.16% from 2022 to 2030. 

The medical polymer market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global medical polymer market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global medical polymer market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global medical polymer market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link https://www.precedenceresearch.com/sample/2142

 Report Scope of the Medical Polymer Market

Report Coverage	Details
Market Size in 2022	USD 20.44 Billion
Market Size by 2030	USD 38.3 Billion
Growth Rate from 2022 to 2030	CAGR of 8.16%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	Product, Application, Processing Method and Geography

This study covers a detailed segmentation of the global medical polymer market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global medical polymer market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• BASF SE
• NatureWorks LLC
• Covestro AG
• Celanese Corporation
• Eastman Chemical Corporation
• Evonik Industries AG
• Dow Inc.
• Exxon Mobil Corporation
• Arkema
• Koninklijke DSM NV
• Formosa Plastics Corporation
• Foryou Medical
• KRATON CORPORATION
• SABIC
• Trinseo S.A.

Market Segmentation

 By Product

• Fibers & Resins
  • PVC
  • PP
  • PE
  • PS
  • Others (engineering thermoplastics such as nylon, PET, PLA, PHA, PA, PC, ABS)
• Medical Elastomers
  • Styrene Block Copolymer
  • Rubber latex (NR + Butyl Rubber+Silicone rubber)
  • Others (TPU, TPO, TPV)
• Biodegradable Polymers
• Polyhydroxyalkanoate (PHA)
• Others

By Application

• Medical Device Packaging
• Medical Components
• Orthopedic Soft Goods
• Wound Care
• Cleanroom Supplies
• BioPharm Devices
• Mobility Aids
• Sterilization & Infection Prevention
• Tooth Implants
• Denture-based Materials
• Other Implants
• Others

By Processing Method

• Blow Fill Seal
• Extrusion Blow Molding
• Injection Stretch Blow Molding
• Others 

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Research Methodology

The research methodology adopted by analysts for compiling the global medical polymer market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global medical polymer market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Polymers Market 

5.1. COVID-19 Landscape: Medical Polymers Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Polymers Market, By Product

8.1. Medical Polymers Market, by Product, 2022-2030

8.1.1 Fibers & Resins

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Medical Elastomers

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Biodegradable Polymers

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Polyhydroxyalkanoate (PHA)

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Medical Polymers Market, By Application

9.1. Medical Polymers Market, by Application, 2022-2030

9.1.1. Medical Device Packaging

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Medical Components

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Orthopedic Soft Goods

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Wound Care

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Cleanroom Supplies

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. BioPharm Devices

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Mobility Aids

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Sterilization & Infection Prevention

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Tooth Implants

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Denture-based Materials

9.1.10.1. Market Revenue and Forecast (2017-2030)

9.1.11. Other Implants

9.1.11.1. Market Revenue and Forecast (2017-2030)

9.1.12. Others

9.1.12.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Medical Polymers Market, By Processing Method 

10.1. Medical Polymers Market, by Processing Method, 2022-2030

10.1.1. Blow Fill Seal

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Extrusion Blow Molding

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Injection Stretch Blow Molding

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Medical Polymers Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Processing Method (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Processing Method (2017-2030)

Chapter 12. Company Profiles

12.1. BASF SE

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. NatureWorks LLC

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Covestro AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Celanese Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Eastman Chemical Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Evonik Industries AG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Dow Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Exxon Mobil Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Arkema

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Koninklijke DSM NV

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com